• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by LumiraDx Inc

LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th
January 05, 2024
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
December 29, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to Appeal
October 27, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening Hub
October 20, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Reports Second Quarter 2023 Results
August 24, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24
August 16, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx’s Point of Care Diagnostics Group Continues Commercial Expansion Announcing a Distribution Agreement with Axonlab for its LumiraDx Platform and Tests
July 31, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Submits First 510(k) Application to the FDA for COVID Ultra Test
June 30, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Receives UK CTDA Approval for COVID Ultra and COVID & RSV Tests
June 20, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Reports First Quarter 2023 Results
May 16, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx to Announce First Quarter Financial Results and Host Quarterly Conference Call on May 16
May 09, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
April 24, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Announces Strategic Refocus and Cost Restructuring Program
April 06, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Reports Fourth Quarter and Full Year 2022 Results
March 21, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Quarterly Conference Call on March 21
March 14, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx to Present at Raymond James Institutional Investors Conference
March 03, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Regains Compliance with Nasdaq Continued Listing Requirements
February 17, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Receives FDA Emergency Use Authorization and UK CTDA Approval for its Fast Lab Solutions Multiplex COVID and Influenza Molecular Assay
February 06, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Announces Commercial Shipment of its Point of Care NT-proBNP Test in Europe, Supporting Heart Health Checks in UK
January 31, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
January 31, 2023
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Announces New Investment for Ongoing Development of its Point of Care Molecular Tuberculosis Test
December 14, 2022
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
Latest Clinicians’ U.S. Survey Identifies Point of Care Testing (POCT) as a Way to Address Healthcare Bandwidth Pressures and Anticipates Future Growth of POCT in Community Testing Centers
December 08, 2022
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test
November 14, 2022
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx Reports Third Quarter 2022 Results
November 09, 2022
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
LumiraDx to Announce Third Quarter Financial Results and Host Quarterly Conference Call on November 9
November 02, 2022
From LumiraDx Inc
Via GlobeNewswire
Tickers LMDX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap